Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in Cancer Epidemiol Biomarkers Prev Retrieve available abstracts of 29 articles: HTML format

Single Articles

June 2025
1. BERKMAN AM, Tran M, Thompson LK, Lerman C, et al
   SECONDARY LUNG CANCER AMONG SURVIVORS OF ADOLESCENT AND YOUNG ADULT CANCER: A POPULATION-BASED STUDY.
   Cancer Epidemiol Biomarkers Prev. 2025.
   PubMed     Abstract available
   
   
   
2. FENLON J, Van Bibber N, Mahlow J, Yamoah K, et al
   Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers.
   Cancer Epidemiol Biomarkers Prev. 2025;34:860-867.
   PubMed     Abstract available
   
   
   April 2025
3. DAVIES MPA, Field JK, Gatto F
   External validation of plasma glycosaminoglycans as biomarkers to improve lung cancer risk stratification.
   Cancer Epidemiol Biomarkers Prev. 2025.
   PubMed     Abstract available
   
   
   March 2025
4. WOODHOUSE P, Jackson L, Kammer MN, Godfrey CM, et al
   Optimizing Biomarker Models for Biologically Heterogeneous Cancers: A Nested Model Approach for Lung Cancer.
   Cancer Epidemiol Biomarkers Prev. 2025.
   PubMed     Abstract available
   
   
   January 2025
5. MAKI KG, Tan NQP, Volk RJ, Toumazis I, et al
   Examining Lung Cancer Screening Uptake in the United States: Recent Research and Limitations of Public-Use Data.
   Cancer Epidemiol Biomarkers Prev. 2025;34:9-11.
   PubMed     Abstract available
   
   
   
6. HAMAD W, Grigore B, Walford H, Peters J, et al
   Biomarkers Suitable for Early Detection of Intrathoracic Cancers in Primary Care: A Systematic Review.
   Cancer Epidemiol Biomarkers Prev. 2025;34:19-34.
   PubMed     Abstract available
   
   
   December 2024
7. LI J, Cao X, Zhang L, Liu A, et al
   Anti-FDX1 Autoantibody as a Potential Biomarker for Non-Small Cell Lung Cancer Detection.
   Cancer Epidemiol Biomarkers Prev. 2024.
   PubMed     Abstract available
   
   
   November 2024
8. TESEMA GA, Tessema ZT, Heritier S, Stirling RG, et al
   Timeliness of lung cancer care and area-level determinants in Victoria: A Bayesian spatio-temporal analysis.
   Cancer Epidemiol Biomarkers Prev. 2024.
   PubMed     Abstract available
   
   
   
9. TSAY JJ, Darawshy F, Wang C, Kwok B, et al
   Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma.
   Cancer Epidemiol Biomarkers Prev. 2024;33:1433-1444.
   PubMed     Abstract available
   
   
   September 2024
10. GUDINA AT, Kamen CS, Hirko KA, Adler DH, et al
    Lung Cancer Screening Uptake Under the Revised United States Preventive Service Task Force Guideline: Assessing Disparities.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    August 2024
11. MULVANEY R, Pan Y, Zhao N, Teles F, et al
    Blood Leukocyte DNA Methylation Markers of Periodontal Disease and Risk of Lung Cancer in a Case-Control Study Nested in the CLUE II Cohort.
    Cancer Epidemiol Biomarkers Prev. 2024 Aug 2. doi: 10.1158/1055-9965.EPI-24-0279
    PubMed     Abstract available
    
    
    July 2024
12. TRENDOWSKI MR, Watza D, Lusk CM, Lonardo F, et al
    Evaluation of the Immune Response within the Tumor Microenvironment in African American and non-Hispanic White Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2024 Jul 2. doi: 10.1158/1055-9965.EPI-24-0333
    PubMed     Abstract available
    
    
    June 2024
13. SMELTZER MP, Akinbobola OA, Ray MA, Fehnel C, et al
    Prevalence of Epidermal Growth Factor Receptor and Programmed Death-Ligand 1 testing in a population-based lung cancer surgical resection cohort from 2018-2022.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
14. BEKELE BB, Lian M, Shrestha P, Nabi O, et al
    Racialized economic segregation and treatment and outcomes of small-cell lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2024 Jun 5. doi: 10.1158/1055-9965.EPI-24-0237
    PubMed     Abstract available
    
    
    
15. PELLINI B, Chaudhuri AA
    Racial Disparities in Early-Stage NSCLC Treatment: A Call for Action.
    Cancer Epidemiol Biomarkers Prev. 2024;33:769-770.
    PubMed     Abstract available
    
    
    
16. THOMAS AL, Rhee J, Fisher JA, Horner MJ, et al
    Fine Particulate Matter, Noise Pollution, and Greenspace and Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cohort.
    Cancer Epidemiol Biomarkers Prev. 2024;33:857-860.
    PubMed     Abstract available
    
    
    May 2024
17. MURPHY SE, Guillermo C, Thomson NM, Carmella SG, et al
    Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    April 2024
18. WANG J, Wang Q, Shi Z, Yan X, et al
    Serum lipid levels, genetic risk, and lung cancer incidence: A large prospective cohort study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
19. ALLAIRE BT, Horvath ML, Lines LM, Davidoff AJ, et al
    Do Contemporary Cancer Survivors Experience Better Quality of Life? Evaluating a Decade of SEER Medicare Health Outcomes Survey Data.
    Cancer Epidemiol Biomarkers Prev. 2024;33:593-599.
    PubMed     Abstract available
    
    
    February 2024
20. BOOKSTEIN A, Po J, Tseng C, Larson TV, et al
    Association between Airport Ultrafine Particles and Lung Cancer Risk: The Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
21. PELLAND-ST-PIERRE L, Pham MC, Nguyen AQH, Pasquet R, et al
    The Influence of Smoking and Occupational Risk Factors on DNA Methylation in the AHRR and F2RL3 Genes.
    Cancer Epidemiol Biomarkers Prev. 2024;33:224-233.
    PubMed     Abstract available
    
    
    
22. DEVASIA TP, Howlader N, Dewar RA, Stevens JL, et al
    Increase in the Life Expectancy of Patients with Cancer in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
    PubMed     Abstract available
    
    
    January 2024
23. YOON HS, Wu J, Shidal C, Sun Y, et al
    Associations between Plasma Tocopherols and Lung Cancer Risk: Results from the Southern Community Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
24. LIU Q, Medina HN, Rodriguez E, Jacobs KT, et al
    Trends and Disparities in Curative-Intent Treatment for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis of Surgery and SBRT.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
25. DUNCAN MS, Diaz-Zabala H, Jaworski J, Tindle HA, et al
    INTERACTION BETWEEN CONTINUOUS PACK-YEARS SMOKED AND POLYGENIC RISK SCORE ON LUNG CANCER RISK: PROSPECTIVE RESULTS FROM THE FRAMINGHAM HEART STUDY.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
26. GRABSKI IN, Heymach JV, Kehl KL, Kopetz S, et al
    Effects of KRAS Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum.
    Cancer Epidemiol Biomarkers Prev. 2024;33:158-169.
    PubMed     Abstract available
    
    
    
27. LI Y, Xiao X, Li J, Han Y, et al
    Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies.
    Cancer Epidemiol Biomarkers Prev. 2024 Jan 5. doi: 10.1158/1055-9965.EPI-23-0613
    PubMed     Abstract available
    
    
    November 2023
28. YANG Z, He H, He G, Zeng C, et al
    Investigating Causal Effects of Hematological Traits on Lung Cancer: A Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Nov 1. doi: 10.1158/1055-9965.EPI-23-0725
    PubMed     Abstract available
    
    
    September 2023
29. WONG JY, Shu XO, Hu W, Blechter B, et al
    Associations between longer leukocyte telomere length and increased lung cancer risk among never smokers in urban China.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.